Transformation of Epithelial Cell by E6 Oncogene
Transformation of Epithelial Cell by E6 Oncogene
批准号:
7247186
负责人:
Lizi Wu
金额:
$20.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2010-05-31
关键词:
AffectBindingBovine PapillomavirusCancer EtiologyCell Cycle RegulationCell NucleusCell ProliferationCellsCervicalCervix carcinomaCessation of lifeCloningComplexDifferentiation and GrowthDrosophila melanogasterEpithelial CellsFamilyFamily memberGenesGoalsHPV-High RiskHumanHuman PapillomavirusHuman papillomavirus 16LeadLinkMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMapsMediatingMolecularNotch Signaling PathwayNuclear ProteinNuclear ProteinsOncogene ProteinsOncogenesOncogenicPapillomavirusPathogenesisPathway interactionsProcessProtein p53ProteinsResearchRiskRoleSignal TransductionSiteTP53 geneTestingTumor Suppressor ProteinsUbiquitinationWomancell growthcell transformationhuman RCN2 proteinhuman UBE3A proteininsightkeratinocytemembermetaplastic cell transformationnotch proteinnovelprotein functionsenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cervical carcinomas are associated with a few specific subtypes of the human papillomavirus (HPV). However, the molecular mechanisms of cellular transformation by these "high-risk" HPV are not fully understood. Two transforming oncoproteins of HPV, E6 and E7, are required for both initiation and maintenance of cellular transformation. The transforming function of E6 is mediated partially by its ability to induce ubiquitination and degradation of the p53 tumor suppressor protein. However, E6 also has poorly understood transformation activities that are p53-independent. These additional E6 activities have critical roles in the pathogenesis of cancers caused by HPV. Recently, we cloned and characterized a novel human E6-binding protein, MAML1 (mastermind-like-I) that selectively interacts with E6 from high-risk HPV type 16. MAML1 is related to the Drosophila melanogaster mastermind gene, a component of the Notch signaling pathway involved in cell fate determination. We found that MAML1, a nuclear protein, functions as a transcriptional co-activator for mammalian Notch receptors. These studies have now led to our cloning and characterization of two additional members of this novel mammalian mastermind family, MAML2 and MAML3. Like MAML1, both MAML2 and MAML3 preferentially bind to E6 from high-risk HPV16. Furthermore, high-risk HPV16 E6 proteins block Notch signaling. Therefore, the MAML family provides the first direct link between papillomavirus oncoproteins and the Notch pathway. The, goal of this proposal is to determine the mechanisms and significance of the HPV E6 interactions with the three mammalian mastermind family members in E6-mediated cellular transformation. The hypothesis to be tested is that HPV E6 interactions with the Notch pathway, via the MAML family, have a critical role in cellular transformation. Specifically, we hypothesize that E6-MAML interactions result in altered Notch signaling and lead to deregulated growth and differentiation in cervical epithelial cells. Alternatively or in combination, E6-MAML interactions may be required for E6 transformation activities involving cell proliferation, cell cycle regulation and senescence. To test these hypotheses, we will 1) determine whether the interactions of high-risk E6 proteins with MAML proteins are critical for E6 mediated cellular transformation, 2) determine whether and how the interactions of E6 and MAML proteins contribute to cellular transformation via Notch signaling. The proposed research will advance our understanding of the molecular mechanisms of transformation of cervical cancers, as well as provide insight into the novel MAML family and the Notch signaling pathway.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Oncogenesis Research Program
-
批准号:10625757
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2023
-
负责人:Lizi Wu
-
依托单位:
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation
-
批准号:10334407
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2019
-
负责人:Lizi Wu
-
依托单位:
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation
-
批准号:10558734
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2019
-
负责人:Lizi Wu
-
依托单位:
A novel noncoding RNA and human lung cancers with inactivated LKB1 signaling
-
批准号:8881623
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2015
-
负责人:Lizi Wu
-
依托单位:
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor
-
批准号:8696318
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2014
-
负责人:Lizi Wu
-
依托单位:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
-
批准号:10439473
-
项目类别:
-
资助金额:$35.15万
-
财政年份:2014
-
负责人:Lizi Wu
-
依托单位:
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor
-
批准号:8907995
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2014
-
负责人:Lizi Wu
-
依托单位:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
-
批准号:10208855
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2014
-
负责人:Lizi Wu
-
依托单位:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
-
批准号:10672248
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2014
-
负责人:Lizi Wu
-
依托单位:
Transformation of Epithelial Cell by E6 Oncogene
-
批准号:6752507
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2003
-
负责人:Lizi Wu
-
依托单位:
Transformation of Epithelial Cell by E6 Oncogene
-
批准号:7317800
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2003
-
负责人:Lizi Wu
-
依托单位:
Transformation of Epithelial Cell by E6 Oncogene
-
批准号:6897945
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2003
-
负责人:Lizi Wu
-
依托单位:
Transformation of Epithelial Cell by E6 Oncogene
-
批准号:6619209
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2003
-
负责人:Lizi Wu
-
依托单位:
Transformation of Epithelial Cell by E6 Oncogene
-
批准号:7070053
-
项目类别:
-
资助金额:$11.58万
-
财政年份:2003
-
负责人:Lizi Wu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: